Authors/Disclosures
|
Jose-Rafael P. Zuzuarregui, MD
(UCSF)
|
Dr. Zuzuarregui has nothing to disclose. |
|
William Chan
(SUNY Downstate)
|
No disclosure on file |
|
Doungporn Ruthirago, MD
(Bangkok International Hospital)
|
No disclosure on file |
|
Bryan Dobbs
|
No disclosure on file |
|
|
No disclosure on file |
|
Michael Shaw
|
No disclosure on file |
|
Margaret Kasschau
|
No disclosure on file |
|
|
No disclosure on file |
|
Lauren B. Krupp, MD, FAAN
(NYU Langone Medical Center)
|
Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care. |
|
Leigh E. Charvet, PhD
(NYU Langone)
|
Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson. |